If Sentinel Nodes Are Positive, How Much Surgery Is Needed? | Professor Fengxi Su

Professor Fengxi Su reviewing node pathology and an axillary teaching model with a colleague.
01 · Understand the question

Does a positive node always mean more surgery?

Not always. Positive means cancer cells were found in a sampled node. It does not automatically mean that more underarm nodes must be removed. Further node removal is called axillary dissection; whether it is needed depends on your findings and treatment plan.

  • Review how many sampled nodes were involved.
  • Ask how the size of the cancer deposit affects the decision.
Discuss node results
A clinician comparing population research with the tools used to examine tissue.

Can a model tell whether more nodes contain cancer?

Professor Su coauthored a study testing models that estimate additional node involvement after a positive sentinel biopsy. A model gives a probability based on a studied group; it is not a diagnosis of your remaining nodes.

  • Prediction is different from examining tissue.
  • Ask whether the model fits patients like you.
Clinicians reviewing prediction research and treatment outcome evidence side by side.

Does a low predicted risk prove I can avoid more surgery?

No. Predicting whether additional nodes contain cancer is different from proving that avoiding further node removal is safe. Decisions also consider evidence about radiotherapy, medicines and outcomes in people with a matching clinical situation.

  • A risk estimate is not proof that less surgery is safe.
  • The team needs the whole treatment context.
A clinician and patient reviewing a lumpectomy report alongside a radiotherapy plan.
02 · Weigh the details

When might I avoid further node removal after lumpectomy?

Some patients with no suspicious underarm nodes on examination can avoid further dissection after one or two sentinel nodes test positive. This applies to selected patients having breast-conserving surgery first, followed by whole-breast radiotherapy. Tumour stage and all other eligibility conditions need checking.

  • This is a selected clinical situation.
  • It is not a rule for every positive node result.
Discuss which guidance applies
A clinician reviewing mastectomy information and regional lymph node radiotherapy planning.

Is the decision the same after mastectomy?

Some patients having mastectomy as their first treatment can avoid further node removal. One guideline-supported example is an invasive tumour no larger than 5 cm, no suspicious nodes on examination, and one or two positive sentinel nodes, with post-mastectomy radiotherapy planned to include regional lymph nodes.

  • Ask which nearby lymph node areas would receive radiotherapy.
  • This is one selected situation, not the only possible case or a rule for everyone.
Original node biopsy, medicine history and surgical pathology documents arranged in treatment order.

What if I had treatment before surgery?

After medicines given before surgery, remaining cancer in a node needs a different assessment. Further node removal is often recommended, and the amount of remaining cancer matters. The rules used after surgery-first treatment do not automatically apply.

  • Bring the original node biopsy and any marking details.
  • Ask how any remaining cancer changes the recommendation.
A rehabilitation clinician assessing shoulder movement beside a lymphatic teaching model.

How is arm function considered?

The team weighs cancer treatment needs alongside the possible effects of underarm surgery. Professor Su’s arm-drainage mapping study showed why arm and breast drainage cannot always be treated as entirely separate pathways.

  • Ask about possible arm complications.
  • Ask which protective or rehabilitation measures are appropriate for you.
A patient noting questions while a clinician explains pathology and treatment documents.
03 · Prepare your next step

What should the recommendation explain?

Ask why further surgery is or is not recommended, how radiotherapy and medicines fit, and which evidence matches your circumstances. The answer should address your actual pathology and treatment sequence.

  • Keep the node report and treatment summary together.
  • Ask what remains uncertain and who will review it.
Discuss reviewing your plan

Evidence and References

This educational guide draws on publications coauthored by Professor Fengxi Su. Additional current guidance is identified separately. The explanations support discussion with your care team and do not determine individual treatment.

Related guides

Use the contact form to ask about consultation arrangements. Sending a message does not confirm an appointment. The form is not an emergency service.